rs754987281
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP6
The NM_001378609.3(OTOGL):c.335-9del variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000185 in 1,592,800 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 0 hom. )
Consequence
OTOGL
NM_001378609.3 splice_polypyrimidine_tract, intron
NM_001378609.3 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.64
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
?
Very rare variant in population databases, with high coverage;
BP6
?
Variant 12-80222079-GT-G is Benign according to our data. Variant chr12-80222079-GT-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 517312.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OTOGL | NM_001378609.3 | c.335-9del | splice_polypyrimidine_tract_variant, intron_variant | ENST00000547103.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OTOGL | ENST00000547103.7 | c.335-9del | splice_polypyrimidine_tract_variant, intron_variant | 5 | NM_001378609.3 | P1 | |||
OTOGL | ENST00000646859.1 | c.335-9del | splice_polypyrimidine_tract_variant, intron_variant | ||||||
OTOGL | ENST00000643417.1 | n.995-9del | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes ? AF: 0.000184 AC: 28AN: 152120Hom.: 0 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
28
AN:
152120
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000191 AC: 44AN: 230474Hom.: 0 AF XY: 0.000230 AC XY: 29AN XY: 125914
GnomAD3 exomes
AF:
AC:
44
AN:
230474
Hom.:
AF XY:
AC XY:
29
AN XY:
125914
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000185 AC: 266AN: 1440562Hom.: 0 Cov.: 30 AF XY: 0.000198 AC XY: 142AN XY: 717096
GnomAD4 exome
AF:
AC:
266
AN:
1440562
Hom.:
Cov.:
30
AF XY:
AC XY:
142
AN XY:
717096
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.000184 AC: 28AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74438
GnomAD4 genome
?
AF:
AC:
28
AN:
152238
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74438
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Aug 04, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 20, 2020 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 21, 2017 | Variant classified as Uncertain Significance - Favor Benign. The c.308-9delT var iant in OTOGL has not been previously reported in individuals with hearing loss, but has been identified in 16/64272 European chromosomes by the Exome Aggregati on Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs754987281). This va riant is located in the 3' splice region. Computational tools do not suggest an impact to splicing. However, this information is not predictive enough to rule o ut pathogenicity. In summary, while the clinical significance of the c.308-9delT variant is uncertain, this data suggests that it is more likely to be benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at